Psyence Group Inc. (CSE:PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and...
Gold and uranium were the major ASX commodities in the winners list in October, while coal and lithium prices continued ... Read More The post Up,...
PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) (“PharmaDrug” or the “Company“), is pleased to announce that it has entered into a definitive agreement...
Psychedelics companies Cybin Inc. (NYSE: CYBN) and Small Pharma Inc. (OTCQB: DMTTF) have completed their August acquisition agreement. Following their...
ATMA and Cena Life Announce Joint-Venture to Support Psychedelic-Assisted Therapy in Canada CALGARY, October 20, 2023 – ATMA Journey Centers Inc. (“ATMA”),...
PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) (“PharmaDrug” or the “Company“), announced today that it will be proceeding with the consolidation of...
Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF)has gotten the green light for its deal with Cybin Inc. (NYSE American:CYBN) (NEO:CYBN). Small Pharma announced...
The financials doesn't include the firm's more recent spending spree. The post Lucy Scientific Debt Climbs in Fiscal Year Report appeared first on Green...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
Cybin Inc. (NYSE AMERICAN:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...